• Regulatory Rapporteur December 2025 – Contents

  • North America: Transparency, transformation and innovation pathways

  • From laboratory to patient: The role of New Substance Notifications in delivering innovative therapies in Canada

  • Cross-functional strategies in clinical data disclosure for EMA Policy 0070 and Health Canada PRCI

  • A year of change for the US FDA: An update on notable pilots and programmes

  • Bringing innovation to market: Regulatory strategy for MedTech companies

  • Bridging the digital divide: A toolkit for equity-centred regulation of digital mental health

  • Medical device standards update: December 2025

  • 2025 Regulatory Intelligence Conference Europe: Meeting report